Management of Patients With Immune Checkpoint Inhibitor-Induced Enterocolitis: A Systematic Review |
| |
| Affiliation: | 1. Department of Gastroenterology, Kremlin Bicêtre Hospital, Assistance Publique-Hopitaux de Paris, Le Kremlin Bicêtre, France;3. Paris Saclay University, Le Kremlin Bicêtre, France;4. INSERM, U1193, Paul-Brousse University Hospital, Hepatobiliary Centre, Villejuif, France |
| |
| Abstract: | ![]()
|
| |
| Keywords: | CTLA-4 Immune Checkpoint Inhibitors PD1 Enterocolitis Immune-Related Adverse Effect Colitis Enteritis Immunotherapy CTLA-4" },{" #name" :" keyword" ," $" :{" id" :" kwrd0050" }," $$" :[{" #name" :" text" ," _" :" cytotoxic T-lymphocyte–associated antigen-4 FDA" },{" #name" :" keyword" ," $" :{" id" :" kwrd0060" }," $$" :[{" #name" :" text" ," _" :" Food and Drug Administration GI" },{" #name" :" keyword" ," $" :{" id" :" kwrd0070" }," $$" :[{" #name" :" text" ," _" :" gastrointestinal IBD" },{" #name" :" keyword" ," $" :{" id" :" kwrd0080" }," $$" :[{" #name" :" text" ," _" :" inflammatory bowel disease ICI" },{" #name" :" keyword" ," $" :{" id" :" kwrd0090" }," $$" :[{" #name" :" text" ," _" :" immune checkpoint inhibitor NSCLC" },{" #name" :" keyword" ," $" :{" id" :" kwrd0100" }," $$" :[{" #name" :" text" ," _" :" non–small-cell lung carcinoma PD1" },{" #name" :" keyword" ," $" :{" id" :" kwrd0110" }," $$" :[{" #name" :" text" ," _" :" programmed cell death 1 PD-L1" },{" #name" :" keyword" ," $" :{" id" :" kwrd0120" }," $$" :[{" #name" :" text" ," _" :" programmed death-ligand 1 TNF" },{" #name" :" keyword" ," $" :{" id" :" kwrd0130" }," $$" :[{" #name" :" text" ," _" :" tumor necrosis factor |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
